FDA Grants Priority Review to Olaparib, Bevacizumab Combination for Ovarian Cancer

Article from Cancer Network curated by Editor in Chief George Lundberg, MD, who notes: 

In precision oncology, drugs combinations may provide new effective treatment.

Go to full article published by Cancer Network.

If you’re wondering whether this story applies to your own cancer case or a loved one’s, we invite you to get support from Cancer Commons.